As shown in Figure 3D, the genetic alteration of PDHA1 showed a poor prognosis in adrenocortical carcinoma (ACC) and KIRC patients and a good prognosis in LUAD patients. This evidence concerns the gene PDHA1 and adrenal cortex carcinoma.